A phase II clinical trial of a natural formulation containing tea catechins for xerostomia

Scott S. DeRossi, Jaisri Thoppay, Douglas P. Dickinson, Stephen Warwick Looney, Mary Stuart, Kalu U.E. Ogbureke, Stephen Hsu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective Previous animal studies indicated catechins from the tea plant (Camellia sinensis) may modulate salivary function and possess a therapeutic effect for xerostomia. The objective of this study was to evaluate a natural formulation containing tea catechins in 60 patients with xerostomia, including patients with Sjögren syndrome. Study Design This study used a double-blind, placebo-controlled, randomized design. The functional placebo contained all natural formulation ingredients and 500 mg xylitol, but without the key plant extracts. Results After 8 weeks of therapy, the xylitol-containing placebo failed to modulate saliva output. In comparison, the catechin-containing natural formulation resulted in a statistically significant increase in unstimulated (3.8-fold) and stimulated (2.1-fold) saliva output vs baseline. The quality of life score showed a significant improvement in both groups but no significant difference between groups. Conclusions The catechin-containing natural formula partially restored salivary function in patients with xerostomia and provided an objective improvement in saliva output, which warrants large-scale clinical trials.

Original languageEnglish (US)
Pages (from-to)447-454.e3
JournalOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Volume118
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Xerostomia
Phase II Clinical Trials
Catechin
Tea
Saliva
Xylitol
Placebos
Camellia sinensis
Plant Extracts
Therapeutic Uses
Quality of Life
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Pathology and Forensic Medicine
  • Dentistry (miscellaneous)
  • Radiology Nuclear Medicine and imaging

Cite this

A phase II clinical trial of a natural formulation containing tea catechins for xerostomia. / DeRossi, Scott S.; Thoppay, Jaisri; Dickinson, Douglas P.; Looney, Stephen Warwick; Stuart, Mary; Ogbureke, Kalu U.E.; Hsu, Stephen.

In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 118, No. 4, 01.01.2014, p. 447-454.e3.

Research output: Contribution to journalArticle

DeRossi, Scott S. ; Thoppay, Jaisri ; Dickinson, Douglas P. ; Looney, Stephen Warwick ; Stuart, Mary ; Ogbureke, Kalu U.E. ; Hsu, Stephen. / A phase II clinical trial of a natural formulation containing tea catechins for xerostomia. In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2014 ; Vol. 118, No. 4. pp. 447-454.e3.
@article{bac2f5d325e44c12a25a36118df5acdb,
title = "A phase II clinical trial of a natural formulation containing tea catechins for xerostomia",
abstract = "Objective Previous animal studies indicated catechins from the tea plant (Camellia sinensis) may modulate salivary function and possess a therapeutic effect for xerostomia. The objective of this study was to evaluate a natural formulation containing tea catechins in 60 patients with xerostomia, including patients with Sj{\"o}gren syndrome. Study Design This study used a double-blind, placebo-controlled, randomized design. The functional placebo contained all natural formulation ingredients and 500 mg xylitol, but without the key plant extracts. Results After 8 weeks of therapy, the xylitol-containing placebo failed to modulate saliva output. In comparison, the catechin-containing natural formulation resulted in a statistically significant increase in unstimulated (3.8-fold) and stimulated (2.1-fold) saliva output vs baseline. The quality of life score showed a significant improvement in both groups but no significant difference between groups. Conclusions The catechin-containing natural formula partially restored salivary function in patients with xerostomia and provided an objective improvement in saliva output, which warrants large-scale clinical trials.",
author = "DeRossi, {Scott S.} and Jaisri Thoppay and Dickinson, {Douglas P.} and Looney, {Stephen Warwick} and Mary Stuart and Ogbureke, {Kalu U.E.} and Stephen Hsu",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.oooo.2014.06.015",
language = "English (US)",
volume = "118",
pages = "447--454.e3",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - A phase II clinical trial of a natural formulation containing tea catechins for xerostomia

AU - DeRossi, Scott S.

AU - Thoppay, Jaisri

AU - Dickinson, Douglas P.

AU - Looney, Stephen Warwick

AU - Stuart, Mary

AU - Ogbureke, Kalu U.E.

AU - Hsu, Stephen

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective Previous animal studies indicated catechins from the tea plant (Camellia sinensis) may modulate salivary function and possess a therapeutic effect for xerostomia. The objective of this study was to evaluate a natural formulation containing tea catechins in 60 patients with xerostomia, including patients with Sjögren syndrome. Study Design This study used a double-blind, placebo-controlled, randomized design. The functional placebo contained all natural formulation ingredients and 500 mg xylitol, but without the key plant extracts. Results After 8 weeks of therapy, the xylitol-containing placebo failed to modulate saliva output. In comparison, the catechin-containing natural formulation resulted in a statistically significant increase in unstimulated (3.8-fold) and stimulated (2.1-fold) saliva output vs baseline. The quality of life score showed a significant improvement in both groups but no significant difference between groups. Conclusions The catechin-containing natural formula partially restored salivary function in patients with xerostomia and provided an objective improvement in saliva output, which warrants large-scale clinical trials.

AB - Objective Previous animal studies indicated catechins from the tea plant (Camellia sinensis) may modulate salivary function and possess a therapeutic effect for xerostomia. The objective of this study was to evaluate a natural formulation containing tea catechins in 60 patients with xerostomia, including patients with Sjögren syndrome. Study Design This study used a double-blind, placebo-controlled, randomized design. The functional placebo contained all natural formulation ingredients and 500 mg xylitol, but without the key plant extracts. Results After 8 weeks of therapy, the xylitol-containing placebo failed to modulate saliva output. In comparison, the catechin-containing natural formulation resulted in a statistically significant increase in unstimulated (3.8-fold) and stimulated (2.1-fold) saliva output vs baseline. The quality of life score showed a significant improvement in both groups but no significant difference between groups. Conclusions The catechin-containing natural formula partially restored salivary function in patients with xerostomia and provided an objective improvement in saliva output, which warrants large-scale clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84922851647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922851647&partnerID=8YFLogxK

U2 - 10.1016/j.oooo.2014.06.015

DO - 10.1016/j.oooo.2014.06.015

M3 - Article

C2 - 25240992

AN - SCOPUS:84922851647

VL - 118

SP - 447-454.e3

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 4

ER -